KUALA LUMPUR: Bursa Malaysia Bhd
may see a tapering of average daily trading value (ADV) in FY22 although at a lower quantum given the prevailing pandemic and slow efficacy of the vaccines.
Kenanga Research said in a note that it expects continued volatility ahead given the risks of a further wave of the pandemic and potential new mutations, while the low interest rate regime is expected to keep domestic retailers' participation robust.
